| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 110,910000 | 20/02/2026 | 4,20% | 5,70% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | BIOTECNOLOGÍA | 109,730000 | 20/02/2026 | 4,20% | 4,73% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 73,860000 | 20/02/2026 | 4,19% | 5,54% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 90,110000 | 20/02/2026 | 4,17% | 5,42% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 107,640000 | 20/02/2026 | 4,12% | 4,17% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) EUR (HEDGED) | BIOTECNOLOGÍA | 107,140000 | 20/02/2026 | 4,12% | 3,95% | ** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC | BIOTECNOLOGÍA | 785,892751 | 20/02/2026 | 4,06% | 19,04% | ** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | BIOTECNOLOGÍA | 2.552,502762 | 20/02/2026 | 4,03% | 43,62% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP USD | BIOTECNOLOGÍA | 6.970,136823 | 20/02/2026 | 4,01% | 43,14% | *** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) (EUR) Q-ACC | BIOTECNOLOGÍA | 122,120000 | 20/02/2026 | 3,99% | 23,02% | ND |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 84,870000 | 20/02/2026 | 3,98% | 1,06% | ** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP USD | BIOTECNOLOGÍA | 335,098156 | 20/02/2026 | 3,96% | 45,88% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | BIOTECNOLOGÍA | 2.884,850000 | 20/02/2026 | 3,85% | 48,22% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP USD | BIOTECNOLOGÍA | 1.038,854423 | 20/02/2026 | 3,84% | 42,05% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C DIS USD | BIOTECNOLOGÍA | 942,772159 | 20/02/2026 | 3,83% | 39,51% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R-H CAP EUR | BIOTECNOLOGÍA | 291,330000 | 20/02/2026 | 3,80% | 50,92% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP EUR | BIOTECNOLOGÍA | 2.964,520000 | 20/02/2026 | 3,79% | 43,38% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY N CAP USD | BIOTECNOLOGÍA | 735,395598 | 20/02/2026 | 3,78% | 40,50% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP EUR | BIOTECNOLOGÍA | 440,050000 | 20/02/2026 | 3,74% | 46,14% | *** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C-H CAP EUR | BIOTECNOLOGÍA | 275,340000 | 20/02/2026 | 3,68% | 47,99% | *** |
